Back to search
FDAFDA · Food and drugs·Recall number Z-2220-2024

CDC, Influenza A/H5 Subtyping Kit, Model/Catalog Number: FluIVD03-11

Published July 3, 2024 · Recall initiated: April 26, 2024

Summary

FDA records medical device Class II recall Z-2220-2024, published July 3, 2024 and initiated April 26, 2024. Recalling firm: Centers For Disease Control and Prevention; Status: Terminated; Reported quantity: 191 units; Lot: Lot Code: Catalog # FluIVD03-11, lot 220307. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The H5b component may fail to amplify, resulting in an inconclusive result.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Centers For Disease Control and Prevention
Distributor
US Nationwide distribution.
Lot
Lot Code: Catalog # FluIVD03-11, lot 220307
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was CDC, Influenza A/H5 Subtyping Kit, Model/Catalog Number: FluIVD03-11 recalled?

Yes. FDA published recall Z-2220-2024 on July 3, 2024. Reported hazard: The H5b component may fail to amplify, resulting in an inconclusive result.

What should I do if I have this product?

Voluntary: Firm initiated · Letter